Oct 14, 2026 07:02AM
Oct 14, 2026 07:00AM
Aug 5, 2026 07:00AM
May 7, 2026 07:10AM
May 7, 2026 07:00AM
May 7, 2026 07:00AM
Feb 26, 2026 07:00AM Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 17, 2026 07:00AM
Jan 8, 2026 07:05AM
Jan 8, 2026 07:00AM
Dec 19, 2025 09:06AM
Mar 25, 2025 06:51AM
Mar 24, 2025 01:50PM
Mar 24, 2025 09:15AM Roth/MKM on Entrada Therapeutics (TRDA): 'we remain bullish on Entrada’s DMD programs'
Mar 24, 2025 07:01AM
Mar 24, 2025 07:00AM
Feb 28, 2025 12:43AM
Feb 27, 2025 07:00AM
Feb 25, 2025 06:49AM
Feb 24, 2025 07:00AM
Feb 24, 2025 07:00AM Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44
Mar 13, 2024 07:00AM
Nov 22, 2023 07:23AM
Nov 22, 2023 07:00AM
Nov 7, 2023 07:00AM
Aug 8, 2023 07:00AM
May 10, 2023 07:00AM
Mar 23, 2023 10:19AM 5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Science
Mar 6, 2023 07:00AM
Mar 6, 2023 07:00AM
Dec 19, 2022 05:38PM
Dec 19, 2022 04:30PM
Dec 19, 2022 04:30PM
Dec 19, 2022 04:30PM
Nov 7, 2022 07:00AM Entrada Therapeutics Reports Third Quarter 2022 Financial Results
Nov 7, 2022 07:00AM
Aug 11, 2022 07:00AM
Aug 11, 2022 07:00AM
Aug 4, 2022 07:05AM
Aug 4, 2022 07:00AM
Aug 4, 2022 07:00AM
May 12, 2022 07:03AM Entrada Therapeutics (TRDA) Reports Q1 Net Loss of $21.7M
May 12, 2022 07:00AM
May 12, 2022 07:00AM
May 11, 2022 09:32AM
May 11, 2022 09:30AM
May 11, 2022 09:30AM

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All